International Journal of Radiation Oncology Biology Physics

Article	Citations
The R's of Radiation Therapy: Do We Need More or Do We Move On?	229
If Medicine were my Spouse	171
In Regard to Langé et al	163
The Positioning Accuracy of Individualized Open-Face Mask in Patients with Intracranial Tumors Receiving Radiotherapy - A Randomized Controlled Study	148
Spatially Fractionated Radiation Therapy (SFRT) Based on Multimodal Imaging: A Promising Salvage Treatment Strategy for Metastatic and Refractory Cancer Patients	111
“Big Jolts Like an Electric Shock:” Patient Perspectives on the Expectations, Experiences and Quality-of-Life Impact of Androgen Deprivation Therapy (ADT) for Prostate Cancer	98
Can Surface-Guided Radiation Therapy (SGRT) be Used to Monitor Intrafraction Motion of Patients Receiving Accelerated Partial Breast Irradiation (APBI)?	92
Locoregional Recurrence and Survival Outcome of HER2-Low Breast Cancer Patients after Upfront Surgery and Adjuvant Radiotherapy	88
The Association of Genetic Polymorphisms in the TNF-α Gene and Mucositis in Head and Neck Cancer Patients Treated with Combined Radiotherapy and Chemotherapy	88
Applying GD-EOB-DTPA Enhanced MR to Unveil the Radiobiological Effect of Proton and Photon Therapy Based on the Longitudinal Evolution of the Focal Liver Reaction	80
Multi-Modality Machine Learning Prediction Model of Hematologic Toxicity in Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer	79
Development of a Consensus Checklist for Systematic Radiation Treatment Plan Review	77
Withdrawn	74
Partial Kidney Radiation Modeling for the Effect of Kidney Dysfunction in Pediatric Cancer	74
Adoption of Hypofractionated and Ultrahypofractionated Adjuvant Radiation Therapy for Breast Cancer Treatment among Providers at a Large Academic Medical Center	70
Predictive Analysis of DQA (Delivery Quality Assurance) Failures in Tomotherapy Plans: Utilizing Plan Parameters and Dosiomics	70
Clinical Outcomes of Patients with Early-Stage Breast Cancer Treated with Five-Fraction Partial Breast Irradiation vs. Intraoperative Radiation Therapy	67
Personalized Minimal Residual Disease Profiling Predicts Prognosis in Esophageal Carcinoma Undergoing Definitive Radiotherapy	65
A Phase II Trial of 5-Day Neoadjuvant Radiation Therapy for Patients with High-Risk Primary Soft Tissue Sarcoma: Long-Term Follow-Up and Outcomes	64
Evaluating the Efficacy of Novel MET-Targeting Camelid Derived Antibody as an Imaging Agent in Head and Neck Cancers	61
Initial Clinical Experience of Cherenkov Imaging in Sub-Total Total Skin Electron Therapy Identifies Opportunities to Improve Daily Set-Up QA	61
Time-Synchronized Immune-Guided Partial Tumor Irradiation: Proof-of-Principle Trial (NCT04168320)	58
A Microbial-Inspired Antibody-Drug Conjugate Unleashes Macrophage Functionalities for Cancer Immunotherapy	56
Phase I/II Prospective Dose Escalation Trial with Proton-Based Radiation Therapy for Chordomas and Chondrosarcomas of the Skull Base and Cervical Spine: Long-Term Results from Proton Radiation Oncolog	54
Spatiotemporal Fractionation Schemes and Additional OAR Sparing for Single-Beam-per-Fraction FLASH-RT Using Transmission Proton Beam	53

Development of Volumetric Quantitative Evaluation Software for Assessing Respiratory-Induced Target Motion	52
Prostate CAncer Integrated Risk Evaluation (P-CARE): A Model to Stratify Risk of Any, Metastatic, and Fatal Prostate	52
Deep Dive into the Performance of the 5D Breathing Motion Model	52
Adaptive Radiation Fractionation in Head and Neck Cancer through Modeling Tumor Volume Dynamics	51
Feasibility of an Online MR-Guided Scan-Plan-Treat Workflow for Emergency Palliation	51
Dosimetric Comparison between Intensity Modulated Radiation Therapy and 3-Dimensional Conformal Radiation Therapy in Both Semi-Lateral Decubitus and Supine Positions for Left Breast Cancer Radiation T	51
Assessing Dose Uncertainties in Cardiac SBRT due to Cardiorespiratory Motion: Photon vs. Proton Therapy Comparison	50
Lost in Lunglation: Unraveling the Mystery of Idiopathic Pulmonary Syndrome Post-Total Body Irradiation for Bone Marrow Transplant	49
Role of Retreatment with Stereotactic Ablative Body Radiotherapy (SABR) in Oligorecurrent Mesothelioma: A Retrospective Monocentric Study	48
Impact of Resident-Lead Didactics on Referring Trainee Radiotherapy Knowledge and Consultation Comfort	47
Decoding Patient Heterogeneity Influencing Radiation-Induced Brain Necrosis	47
Geographical Comparison of Medicare & Medicaid Services (CMS) Standard Charges for Complex Proton Therapy	46
A Single Arm Phase II Study of Neoadjuvant Chemoradiotherapy and AK104 in pMMR/MSS Locally Advanced Rectal Cancer with Positive PD-L1 Expression	45
Microboost and Dosimetric Variability in Localized Prostate Cancer: Analysis of a Prospective Statewide Quality Collaborative	45
Transforming into a Trauma-Informed Care Radiation Oncology Department: Training Program Design, Execution and Evaluation of our Program's Impact	44
A Meta-Analysis of Daily vs. Nonconsecutive Fractionation Schedules for Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer	43
Association of Biologically Effective Dose and Survival in Patients Receiving Head and Neck Stereotactic Body Radiation Therapy	43
Stereotactic Body Radiation Following Prior Radiotherapy for Pancreatic Cancer: A Single Institution Experience	42
Safety Profile of Durvalumab (D) as Consolidation Treatment (tx) in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) in ADRIATIC: Focus on Pneumonitis and Immune-Mediated Adverse Events (imAEs)	42
Predictors of Local Failure in the Durable Palliation of Recurrent Breast Cancer Following Concurrent Hyperthermia and High Dose Radiation	42
Timing of Once-Daily Thoracic Radiotherapy and Clinical Outcomes in Patients with Limited-Stage Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy	42
Synergistic Potential of CDK4/6 Inhibitors and Radiotherapy with Anti-PD-L1 Immunotherapy in Triple-Negative Breast Cancer	41
Local Control of Merkel Cell Carcinoma Treated with Standard of Care Radiation Therapy Compared to Palliative Dose Radiation Therapy	41
Time-Delayed Contrast-Enhanced T2-FLAIR and Accuracy of GTV Determination in Brain Metastases	41
Local Disease Control in Patients with Erdheim-Chester Disease Treated with External Beam Radiation Therapy	41
Re-Irradiation in Children with Recurrent Medulloblastoma	40
Long-Term Outcomes after Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer	40
Accelerated Partial Breast Irradiation for Low-Risk Hormone-Sensitive Breast Cancer is Underutilized but Increasing in the National Cancer Database 2010-2021	40
Identification of Triapine as a Novel Radiosensitizer in Glioblastoma	40
Mind Over Matter: Complete Craniospinal Irradiation or Just Treat the Spine	40
Micro-Costing Analysis of Rectal Spacers in Prostate Cancer Treatment with Radiotherapy	40
Prostate-Specific Membrane Antigen-Directed Focal Stereotactic Radiation Therapy in Two Fractions for Locally Recurrent Prostate Cancer after Definitive Radiation Therapy	39
Managing for Daily Improvement: A System for Real-Time Quality Improvement and Patient Safety	38
Treatment of Patients with Gastric Extranodal Marginal Zone Lymphomas (MZL) Using CBCT-based Adaptive Radiotherapy (ART) to Reduce Margins	38
A Pilot Comparative Study of Mouthbite Devices and Their Effect on Patient Experience and Treatment Setup	38
Risk of Death in Octogenarians with Intermediate Risk Prostate Cancer Who Are Treated with Radiation Therapy (RT) Plus Androgen Deprivation Therapy (ADT) Versus Radiation Alone, an NCDB Analysis	38
The Feasibility Study of Dual-Energy CT Virtual Non-Contrast instead of True Non-Contrast in Proton Radiotherapy Dose Calculation	37
Optimizing Radiation Treatment for Glioblastoma Patients: Contrasting Dosimetric Profiles of HyperArc and Volumetric Arc Therapy	37
Reducing Patient Safety Risk with the Implementation of Intradepartmental Survey Program across a Multi-Site Large Teaching Institution	37
Estimating Risk of Biochemical Recurrence after RT Utilizing a Convolutional Neural Network	37
Developing Blood Sparing Radiotherapy Following CAR T for Lymphoma	37
Comparison between Proton LET-Dependent RBE Dose and Photon Physical Dose for Acute Radiation Dermatitis in Caucasian and African-American Breast Cancer Patients Undergoing Radiation Therapy	37
Association of Inpatient Radiation Oncology Consult Timing with Length of Hospitalization and Opioid Utilization	36
Prognostic Factors for Early Demise Following Palliative Spatially Fractionated Radiotherapy	36
Conventionally Fractionated Reirradiation of Recurrent High-Grade Gliomas: A Look at Dose Escalation and Safety	36
Effect of Postmastectomy Radiotherapy in Breast Cancer Patients according to Pathologic Nodal Status and Molecular Subtype after Neoadjuvant Chemotherapy	36
Mid-Range Arc Therapy—Enhancing Dosimetric Quality, Robustness and Efficiency for Proton Treatment with Simple Planning	36
Optimal Threshold of Smoking in Pack-Years and its Association with Survival Outcomes Among Patients Treated with Chemoradiation for Head and Neck Cancer	35
The LMP1/Lgals1-NF-Kb-IRF1-PDL1 Axis Promotes Immune Escape in Nasopharyngeal Carcinoma	35
Brachytherapy Capacity for Management of Cervical Cancer in Low- and Middle-Income Countries: An Updated IAEA Database Analysis	35

Breast Cancer Radiotherapy Experience in a Newly Established Cancer Center in Nigeria	35
Radiation Necrosis Risk in NSCLC Patients Receiving EGFR TKIs or ALK Inhibitors	35
Dose-Escalated Ablative Radiotherapy as Definitive Treatment for Unresectable and Recurrent Intrahepatic Cholangiocarcinoma	34
Retrospective Analysis of Proton Beam Therapy for Postoperative Locally Recurrent Rectal Cancer	34
Trends in Private Equity Involvement in Oncology Practices in the United States	34
In Silico Trial of Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for the Treatment of Abdominal Oligometastases	34
Salvage Ablative Radiation Therapy for Isolated Intraabdominal Recurrences of Hepatocellular Carcinoma	34
Risk of Diabetes Mellitus after Radiotherapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma	34
Hypofractionated vs. Conventionally Fractionated Radiotherapy for Glioblastoma: Peripheral Blood Leukocyte Comparison prior to and Following Chemoradiation	34
Clinically Consistent Prostate Cancer Outcome Prediction Models with Machine Learning	33
Perineural Invasion Combined with Pattern C of the Silva Classification System Correlates Poor Prognosis in Cervical Adenocarcinoma Following a Radical Hysterectomy	33
Does hippocampal atrophy correlate with patient-reported adaptive function one year following radiotherapy? Results from a prospective trial	32
Novel Enhancement of Checkpoint Inhibition Using Pulsing Radiotherapy with Concurrent and Adjuvant CPI for LAHNSCC in Elderly Patients Considered Ineligible for Curative Intent Therapy	32
Prevalence and Functional Impact of Vertigo among Long Term Survivors of Head and Neck Cancer	32
A National Cancer Disparities Analysis of Pacific Islanders Who Decline Radiation Therapy and Impacts on Overall Survival	32
Overall Survival after Y-90 Selective Internal Radiotherapy of Liver Metastases in Oligometastatic Patients	31
Assessment of Nutritional and Imaging Biomarkers to Predict PEG Tube Placement in Non-HPV-Associated Head and Neck Patients Undergoing Concurrent Chemoradiotherapy	31
Clinical Outcomes in High Risk WHO Grade II Glioma Patients Treated with Upfront TMZ-Based Chemoradiotherapy	31
Lymph Node Metastasis Spread Patterns and the Effectiveness of Prophylactic Neck Irradiation in Sinonasal Squamous Cell Carcinoma (SNSCC)	31
Novel Bioprinted Pancreatic Tumor Model: A Translational Tool for Radiotherapy, Chemotherapy and Immunotherapy Efficacy Studies	31
Meetings page	31
Predictors of Interstitial Brachytherapy Utilization in Locally Advanced Cervical Cancer and Impact on Overall Survival	31
Systematic Implementation of Effective Quality Assurance Processes for the Assessment of Radiation Target Volumes in Head and Neck Cancer	31
Issue Highlights page	30
The Maximum Standardized Uptake Value in Patients with Recurrent or Persistent Prostate Cancer after Radical Prostatectomy and PSMA-PET-Guided Salvage Radiotherapy – A Multicenter Retrospective Analys	30
Pivotal Roles of Tumor-Draining Lymph Nodes in the Abscopal Effect from Combined Immunotherapy and Radiotherapy	30
Low Utilization of External Beam Radiation Therapy for Patients With Unresectable Hepatocellular Carcinoma: An Analysis of the United Network for Organ Sharing Database	30
NAUTIKA1: A Multicenter Phase II Study with a PD-L1+ Cohort of Patients Receiving Atezolizumab (Atezo) with Low-Dose Stereotactic Body Radiation Therapy (SBRT) as Neoadjuvant Therapy for Resectable St	30
Postoperative Radiotherapy can Improve the Disease-Free Survival of EGFR Wild Type Patients with pN2 NSCLC after Complete Resection and Adjuvant Chemotherapy	30
Effectiveness of Adjuvant Radiotherapy for High Recurrence Risk Patients with Upper Tract Urothelial Carcinoma	30
Withdrawn	30
Comparison of Diagnostic PET and 4D CT-Based Tumor Delineation for Oligometastatic Lung Tumors	29
The Use of Breast Cup Immobilization in Radiation Therapy and Patient Reported Outcomes on Cosmesis and Pain	29
Stereotactic Arrhythmia Radioablation for Ventricular Tachycardia (StAR-VT): A Single Institution, Dose De-Escalation, Phase II Trial	29
Single Fraction HDR Brachytherapy for Prostate Cancer: SiFEPI Phase II Trial Results	29
Withdrawn	28
Does Operability Status Influence Outcomes in Patients with T4 Larynx Cancer Undergoing Larynx Preservation?	28
Evaluation of Patient and Tumor Features to Optimize Urothelial Metastasis Treatment	28
Outcomes Associated with the Use of Tissue Equivalent Bolus Tailored by Skin Involvement Status in Postmastectomy Radiotherapy: A Single-Blinded Randomized Clinical Trial	28
Improving Interpretability of Machine Learning in Head and Neck Radiation Therapy Pretreatment Physics Plan Reviews	28
Impact of a Head and Neck Cancer Chemoradiation (HNC CRT) Nurse Practitioner (NP) on Patient Outcomes	28
The Utility of Mean Apparent Diffusion Coefficient Value in Patients with Prostate Cancer Treated with Definitive Radiotherapy	28
Disease-Free Survival of Patients with Muscle Invasive Bladder Cancer Treated by Radical Cystectomy vs. Bladder-Sparing Therapy at a Nationwide Level	28
Effects of Expansion Size from Gross Tumor Volume to Planning Target Volume on Control Rates and Patterns of Recurrence in Conventionally Fractionated Radiotherapy for WHO Grade I Meningiomas	28
Genomic and Transcriptomic Remodeling by Neoadjuvant Chemoradiotherapy (nCRT) and the Indicative Role of Acquired INDEL Percentage for nCRT Efficacy in Esophageal Squamous Cell Carcinoma	27
Non-Canonical p16-SP1 Signaling in Head and Neck Cancer Potentially Affects Cell Plasticity	27
Communicating the External Beam Radiotherapy Experience (CEBRE) Discussion Guides: Real World Implementation and Evaluation	27
Stereotactic Body Radiation Therapy for Large Volume Solid Tumor Spinal Metastases Involving Three or More Contiguous Vertebral Levels	27
Is a Deep Learning Based Segmentation Model Trained on planning CTs Transferable for Segmentation of Organs at Risk in Replanning CTs?	27
Intraoral Gavage of Second-Generation Probiotic Lactobacillus Reuteri Releasing IFN-β (LR-IFN-β) Mitigates Intestinal Irradiation Toxicity and Improves Survival During Whole Abdomen Irradiation (WAI)	27
In Reply to Takiar and Beadle	27
Association between Liver Metastases and Treatment Response in Patients with Metastatic, Microsatellite Stable Colorectal Cancer Treated with Radiation Therapy and Dual Immune Checkpoint Blockade	27
The Baseline Serum Lipid Levels and Outcomes of NSCLC Patients Receiving Immunotherapy Combined or Non-Combined with Radiotherapy: A Single Center Retrospective Study	26
A Randomized Controlled Phase Ⅱ Study of Nab-Paclitaxel vs. Paclitaxel plus Cisplatin in Concomitant Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer	26
Outcomes of MR-Guided Stereotactic Body Radiotherapy (MRgSBRT) for Adrenal Metastases: A Multi-Institutional Pooled Analysis	26
Pre-Clinical Validation of Targeting Cholesterol Metabolism for Radiotherapy Sensitization in Head and Neck Cancer	26
Single Dose vs. Fractionated High-Dose Rate Brachytherapy in Localized Prostate Cancer: Long Term Results	26
Identification and Dosimetric Analysis of Axillary Substructures Associated with Breast Cancer Related Lymphedema	26
Withdrawn	26
Phase II Clinical Trial of Hypofractionated Image-Guided Proton Therapy with 12 Fractions for Prostate Cancer	26
Withdrawn	26
A Phase 2 Multi-Center, Placebo-Controlled, Randomized Study to Assess the Safety and Efficacy of Parenteral TK-90 for Preventing Radiation-Induced Mucositis in Patients with Squamous Cell Carcinoma o	25
Evaluating Heterogeneity of Hippocampal Avoidant Whole Brain Radiotherapy (HA-WBRT) Treatment Effect on Neurocognitive Function (NCF): Secondary Analysis of NRG-CC001	25
Who Knows When it is Right Under Your Nose? A Case of Cutaneous Squamous Cell Carcinoma with Involvement of the Nasal Vestibule	25
Rays Over Knife	25
Real Time Volumetric MRI for MR-Guided 3D Motion Tracking via Sparse Prior-Augmented Neural Representation Learning	25
Prognostic Significance of the Novel Nutrition-Inflammation Marker of Lymphocyte-C-Reactive Protein Ratio in Patients with Nasopharyngeal Carcinoma Receiving Concurrent Chemoradiotherapy	25
Comparison of Two Phase II Trials of Neoadjuvant Temozolomide Followed with Concomitant and Adjuvant Temozolomide and Hypofractionated Accelerated Radiotherapy with or without Metformin in Patients wi	25
Maximization of Peak-to-Valley Dose Ratio and Normal-Tissue Survival Fraction for Proton Minibeam Radiation Therapy	25
Incidence of Major Depression, Suicidal Ideation, and Mental Health Treatment Amongst Cancer Survivors	25
Deployment of a Deep Learning Automated Cardiac Sub-Structure Contouring Algorithm to Measure Coronary Dose Exposure Trends in Lung Cancer Radiation Therapy	24
In Regard to Hammer et al.	24
The Dutch Initiative for the Model-Based Selection of Patients for Proton Therapy – A Federated Learning IT Infrastructure	24
Less Is More: Lower Doses for Intermediate-Term Oropharyngeal Control	24
Initial Experience with the Commercial Electron FLASH Research Extension	24
Tipping the Balance: Adding Resources for Cervical Cancer Brachytherapy	24
IL-1β+ Tumor Associated Macrophages Induced by Type I Interferon Initiates Radiotherapy-Mediated Abscopal Effect	24
Prospective Longitudinal Assessment of Quality of Life after Stereotactic Ablative Radiotherapy for Oligometastases: Analysis of the Population-Based SABR-5 Phase II Trial	24
DCE-MRI-Based Atlas for Prostate Bed Recurrence after Radical Prostatectomy: Consistency of CTV Delineation with the Available Contouring Guidelines	24
Validation of Lexicographic Optimization-Based Planning for Brain Metastases Radiosurgery with Coplanar Arcs	24

Largest Real-World Data of Regional Nodal Irradiation Using Ultra-Hypofractionated 5-Fraction Adjuvant Radiation Therapy for Breast Cancer from a Single Institute in India	24
Financial Toxicity in Patients with Gynecologic Cancer Undergoing Brachytherapy	24
A Pilot Study of Head and Neck Cancer Patients Treated Daily with an Intraoral Photobiomodulation (PBM) Device while Undergoing IMRT Demonstrates Tolerability, Safety, and Preliminary Efficacy for Red	23
Combination of Radiotherapy and Atezolizumab plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Pilot Study	23
Less Is More: A Hypofractionated Approach	23
Incidence of Flap Failure Following Sinonasal Surgery, Flap Reconstruction and Postoperative Proton Radiation Therapy	23
Interpretable Deep Learning Identified the Significance of 1 Gy Volume on Lymphopenia after Radiotherapy in Breast Cancer	23
Patient-Specific Deep Learning Auto-Segmentation for MR-Guided Adaptive Radiotherapy of Prostate Cancer	23
Randomized Clinical Trial of Tele-Surveillance and Remote Symptom Monitoring Compared to Standard Surveillance for HPV-Associated Oropharynx Cancer with No Evidence of Disease on Post-Treatment Imagin	23
Issue Highlights page	23
How the Underlying Etiology of Cirrhosis Impacts Response to SBRT	23
Correlation between Lymph Node Regression Grading and Tumor Regression Grading after Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer	23
A New Pos-SIB-ility for Prostate and Pelvic Nodal Radiation Therapy in High-Risk Localized Prostate Cancer	23
Arytenoid-Sparing Intensity-Modulated Radiotherapy for Early-Stage Glottic Cancer	23
Contralateral Nodal Relapse (CLNR) in Well Lateralized Oral Cavity Cancer Treated Ipsilaterally with Surgery and Adjuvant Radiotherapy with or without Concurrent Chemotherapy: A Retrospective Audit	22
Dose-volume Predictors of Radiation Pneumonitis Following Thoracic Hypofractionated Radiotherapy	22
HyperArc Planning for Benign Intracranial Pathologies: A Prospective Analysis on Plan Quality, Delivery, Control and Toxicity	22
Symptomatic Posttreatment Edema after Stereotactic Radiotherapy for Intracranial Meningiomas: Patterns and Predictive Factors	22
The Effect of Package Time on Locally Advanced Oral Cavity Cancer Outcomes	22
Prospective, Cell-Free Circulating Tumor DNA (ctDNA) Profiling in Locally Advanced Lung Cancer Treated with Chemoradiation	22
Hyperfractionated and Accelerated Reirradiation for Angiosarcoma Following Breast-Conserving Therapy: Long-Term Clinical Outcomes	22
Balancing Quality and Efficiency of Head and Neck Contour Revision for Online Adaptive Radiotherapy	22
Vertex Position Optimization for LATTICE Therapy	22
Putting the Brakes on Xerostomia in Oropharyngeal Cancer: Can Brachytherapy Be the Key?	22
Sarcopenia as a Predictor of Neoadjuvant Therapy-Related Toxicity in Esophageal Squamous Cell Carcinoma Patients	22
A Molecular Approach to Characterize the Effects of Fluence, Fluence Rate and LET on Radiation Damage	21
In Reply to Goyal and Madan	21
Dosimetric Factors Associated with Esophagitis Following Hypofractionated Radiotherapy to the Thorax	21
Rapid Reinstatement of Cancer Care after Hurricane Ian	21
A Novel Multi-Channel Tandem Applicator for Direction Modulated Brachytherapy	21
Long Term Results of Prostate Cancer Patients Treated with Cs131 LDR Brachytherapy Compared with Recently Published SBRT Data	21
International Clinical Radiotherapy Audit in CCCN- iPAAC Project	21
Assessment of Cardiac Radiation Dose in the Co-60 Prone Based Stereotactic Partial Breast Irradiation (CP-sPBI) Using the Distance from the Heart to the Planning Treatment Volume as a Surrogate Marker	21
Irradiation Dose to the Swallowing Muscles Impacts Nutritional Status in Head and Neck Cancer Patients: The Prospective Randomized HEADNUT Trial	21
Combined Brachytherapy and Ultra-Hypofractionated Radiotherapy for Intermediate-Risk Prostate Cancer: Comparison of Toxicity Outcomes Using a High-Dose Rate (HDR) vs. Low-Dose Rate (LDR) Brachytherapy	21
Clinical Outcomes in cN+M0 Bladder Cancer Patients: Can Bladder be Spared?	21
Evaluating the Use of SGRT and Abdominal Compression Device for Improved Patient Positioning in Liver Cancer Radiotherapy	21
The Impact of TP53 Mutations and Use of the TP53-Mutation-Reactivating Agent APR-246 on Metastatic Castrate-Sensitive Prostate Cancer	21
Multitask AI Models for the Joint Prediction of Overall Survival, Progression-Free Survival, and Death without Progression as a Composite Endpoint for LA-NSCLC Patients Treated with Chemoradiotherapy	21
The Role and Mechanism of Ferroptosis Mediated by METTL3-m6A Modification in Regulating Radioresistance of Esophageal Cancer	21
Prospective Evaluation of Locoregional Control in Oral Cavity Squamous Cell Carcinoma with Infratemporal Fossa Involvement Treated with Surgery and Adjuvant Concurrent Chemoradiotherapy	21
Accelerated Partial Breast Irradiation (APBI) Using Five Daily Fractions: A Prospective, Phase II, Multi-Center Trial of Cosmetic Outcomes and Toxicity: Final Results	21
A Radiation Therapy Contouring Atlas for Delineation of the Level I-II Axilla in the Prone Position	21
The Rise of Artificial Intelligence in Radiation Oncology Residency Applications: An Analysis of Applicant Personal Statements, 2015 to 2024	20
Geometric and Dosimetric Evaluation of Using a Novel Tongue Positioning Device to Reduce Tongue Motions during Radiation Therapy for Head and Neck Cancer	20
Atypical Nodal Involvement From an Atypical Meningioma	20
Impact of Body Composition on OAR Dose in Locally Advanced Cervical Cancer Treated with HDR Intracavitary-Interstitial Applicators	20
Prediction of PACIFIC Regimen Efficacy by Measuring Serum Autoantibody Response Against Cancer Antigens Using the MUSCAT Assay	20
Optimal Proton Energy Layer Spacing for Arc Therapy of Brain with Pencil Beam Scanning	20
Different Detection Rates of Brain Metastasis in Different Pathological Types of Lung Cancer by 18F-FAPI PET/CT	20
Advancing beyond the Hippocampus to Preserve Cognition for Patients with Brain Metastases: Dosimetric Results from a Phase 2 Trial of Memory-Avoidance Whole Brain Radiotherapy	20
Improving the Efficacy and Safety of Concurrent Chemoradiotherapy by Neoadjuvant Chemotherapy: A Randomized Controlled Study of Locally Advanced Cervical Cancer with a Large Tumor	20
Deep Learning-Based Synthetic CT Generation from MRI for Head and Neck Cancer Radiation Therapy Planning	20
Evaluating Short Course Radiation and ctDNA for Organ Preservation: The Nonoperative Management and Early Response Assessment in Rectal Cancer (NOM-ERA) Trial	20
Education Opportunities Presented by the Radiation Oncology Virtual Education Rotation	20
Toxicity Outcomes at 18 Months for Cs-131 Low-Dose-Rate Prostate Brachytherapy Compared to I-125 and Pd-103	20
Withdrawn	20
Feasibility of Photon Based Ultra-High Dose Rate Therapy - Using kVp X-Ray Tubes	20
Mapping Single-Cell ecDNA Dynamics in Glioblastoma with CRISPR Lineage Tracing	20
A Real-World Comparison of Moderated Hypofractionated Radiotherapy and Conventional Fractionated Radiotherapy in Cervical Cancer	19
Radiosurgery for Pediatric Central Nervous System Lesions ― Initial Report and Insights from a Multicenter Registry	19
Efficacy and Safety of All-Site Radiation Therapy and Standard of Care Therapy with or without Docetaxel for Hormone-Sensitive High Gleason Score Prostate Cancer: 6-Year Results from a Long-Term Study	19
Stereotactic Body Radiation Therapy (SBRT) to Sites of Oligoprogression during Lutetium-177-PSMA-617 (Lu-PSMA) Treatment for Metastatic Castrate Resistant Prostate Cancer	19
Withdrawn	19
CoVART: A Retrospective Cohort Study of Conventionally Fractionated RT vs. Ablative RT Dosing in the Treatment of Locally Advanced Pancreatic Cancer	19
Multitask Double Machine Learning for Counterfactual Estimation of Survival and Toxicity in Locally Advanced Non-Small Cell Lung Cancer Chemoradiotherapy	19
HYPCON 03 Pilot Study: A Study Exploring Delivery of 3Gy per Fraction in Post Operative Radiotherapy for Head and Neck Carcinomas	19
Resident-Led Quality Improvement Incentive Program in Radiation Oncology: 14-Year Experience at a Single Institution	19
A Clinical Validation Study of Ionizing Radiation Acoustic Imaging (iRAI) for Real-Time Visualization of Radiation Therapy Dose in Liver Cancer Patients	19
Association between Intraoperative Dosimetric Parameters and Urinary Acute and Late Toxicity after Low-Dose-Rate Brachytherapy	19
Examining Treatment and Outcome Disparities in Lung Cancer Among Northern Plains American Indians and Non-Indigenous Populations	19
PSMA-PET Guided Metastasis-Directed Therapy	19
A Pre-Clinical Study of Hyperbaric Oxygen Therapy to Enhance Radiosensitization of Glioblastoma	19
Predicting Response to 177Lu-PSMA-617 Using Pre-Treatment Clinical Biomarkers	19
Real-World Results Comparing Treatment Outcomes: Once or Twice Daily Thoracic Radiotherapy in Younger and Older Patients with Limited-Stage Small Cell Lung Cancer	19
Do Uniform Fasting Instructions Lead to Reproducible Stomach Volumes that Decrease the Proximity of the Stomach to the Target for Pancreatic Cancer Patients?	19
Long-Term Failure Patterns and Prognostic Factors in a Randomized Dose-Escalation Trial for Skull Base Chordomas: A Secondary Analysis from PROG 85-26.	19
Efficacy and Safety of Thermoplastic Film Thermostatic Heating in Radiotherapy for Upper Abdominal Tumors: A Prospective Randomized Controlled Trial	19
Postmarketing Surveillance of Adverse Events after Immune Checkpoint Inhibitor Therapy and Radiotherapy	19
Multi-omics Profiling Links Immunosuppressive Plasma Cells within Tertiary Lymphoid Structures to Clinical Survival in Cervical Cancer Patients Undergoing Chemoradiotherapy	19
Experimental Index Fund Investment vs. Historical NIH Grant Application Strategy to Fund Clinical Radiation Oncology Research	19
Stereotactic Radiotherapy Boost in Locally Advanced Cervical Carcinoma Patients (STARBACS): Up-to-Date Results of a Phase II, Single Arm, Monoinstitutional Study	18
Genomic Mutation-Driven Stratification of Treatment Response to Stereotactic Spine Radiosurgery in Spinal Metastases	18
Clinical Outcomes and Safety of the Combination of External Beam Radiotherapy with 177Lu-DOTATATE	18
Effect of Adjuvant Treatment Modality on Survival Outcomes by FIGO Grade in Locally Advanced Endometrial Cancer	18
In Vivo Dosimetry for Ultra High Dose Rate Irradiation of Rat Spinal Cord with a Novel Scintillation Detector	18
Progression-Free Survival in Grade 2-3 Meningiomas: A Retrospective Analysis of Surgical and Radiotherapy Treatment Approaches at One Institution	18
Updated Results of RESTART Protocol (RadiothErapy bridging and conSolidaTion for CAR-T) in Large B-cell Lymphoma	18
Exploring the Efficacy and Optimal Duration of Tumor Treating Fields (TTFields) in Newly Diagnosed Who Grade 4 Gliomas: A Multi-Institutional Analysis	18
A Dynamic Treatment Strategy for Oligometastatic CSPC: Integrating Molecular Imaging and SBRT to Personalize Systemic Therapy Intensification and De-Intensification	18
A Novel Spot-Scanning Proton Arc(SPArc) Optimization Algorithm for Single Energy Extraction(SEE) Synchrotron-Accelerator-Based Proton Therapy System (PTS): Compelling Initial Results	18
Does the Addition of Chemotherapy to Adjuvant Radiation Benefit the Survival for Patients with Adenocarcinoma of Cervix after Radical Surgery? A Single-Center Retrospective Cohort Study	18
Withdrawn	18
Radiation Therapy Effects on Spectroscopic MRI Metabolites in Recurrent Glioblastoma	18
Comparison of Adaptive Magnetic Resonance Guided and Computed Tomography Guided Stereotactic Body Radiation Therapy for Prostate Cancer	18